• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD¿ SECONDARY SET C61; ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD¿ SECONDARY SET C61; ADMINISTRATION SET Back to Search Results
Catalog Number 515302
Device Problem Unintended Ejection (1234)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/05/2019
Event Type  malfunction  
Manufacturer Narrative
The manufacturing location for this product is (b)(4).This site is an oem manufacturing site.(b)(4).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that bd¿ secondary set c61 had leakage at the junction between set and needle.Customer¿s verbatim: ¿ leakage at junction between infusion set and needle.¿.
 
Manufacturer Narrative
The following fields were updated due to additional information: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 1011186.Medical device expiration date: 2022-04-30.Device manufacture date: 2019-01-31.Medical device lot #: 1011464.Medical device expiration date: 2022-08-31.Device manufacture date: 2018-09-01.
 
Event Description
It was reported that bd¿ secondary set c61 had leakage at the junction between set and needle.Customer¿s verbatim: ¿leakage at junction between infusion set and needle¿.
 
Manufacturer Narrative
Investigation: dhr review was done and no issues were reported during production of this lots.2 sample received for this complaint (lot : 1011464) 1 in original packaging and one in used condition still attached to nacl bag decontaminated.2 samples both from lot 1011464 were tested and one in original packaging passed all tests one in used condition was leaking at spike-tube joint.Ct scan was done on leaking sample which was segregated during production.After this scan additional tests were done on spike component and concentricity of lower part of spike component cause molding deficit on one side of component.Capa#891423 was initiated.
 
Event Description
It was reported that bd¿ secondary set c61 had leakage at the junction between set and needle.¿ leakage at junction between infusion set and needle¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ SECONDARY SET C61
Type of Device
ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
MDR Report Key8438345
MDR Text Key139444235
Report Number2243072-2019-00530
Device Sequence Number1
Product Code LHI
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup,Followup
Report Date 06/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2022
Device Catalogue Number515302
Device Lot NumberSEE H.10
Was Device Available for Evaluation? No
Date Manufacturer Received03/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-